Published April 1, 1998 | Version v1
Journal article

Spatial reproducibility of the ring and tandem high-dose rate cervix applicator

Description

Purpose: High-dose rate (HDR) applicators for uterine cervix brachytherapy are used with increasing frequency. Because multiple HDR fractions are required for treatment, the applicator position reproducibility is of most importance. To study this effect, the clinical data from patients with uterine cervix cancer were examined retrospectively to evaluate the interfraction geometric variation of the HDR applicator and its potential treatment impact. Methods and Materials: Eighteen patients with invasive cervical cancer who were treated with definitive radiotherapy at William Beaumont Hospital were included in the study. Patients were treated with 45-50.4 Gy megavoltage external beam to the pelvis, and 35 Gy to the prescription point A from 7 fractions of HDR brachytherapy. The 3-dimensional (3D) interfraction geometrical variation of the ring and tandem (R and T) applicator was measured using predefined reference points in the 7 sets of orthogonal simulation films obtained prior to each HDR application. Spatial reproducibility of the R and T insertion and time-trend of the R and T position variation related to patient's anatomy during the treatment course were analyzed with respect to different groups of patients who had either early or advanced disease. Results: The translational variation of the applicator position for all patients was 6.5, 5.9, and 7.7 mm (one standard deviation), respectively, in the patient's superior-to-inferior (SI), right-to-left lateral (RL), and anterior-to-posterior (AP) direction. The rotational variation was 3.4, 4.6, and 6.0 degrees (one standard deviation) in the patient's coronal, transverse, and sagital planes. When the patients were grouped based on early disease or advanced disease, the latter demonstrated substantially larger variation (factor of 2) in the applicator position than the former. Furthermore, the time-trend of position variation was observable for both groups of patients. The variations occurred primarily during the first 3 fractions. Conclusions: Based on the good spatial reproducibility observed in our study, the current clinical procedure for the HDR R and T applicator placement is reliable. Positional reproducibility of the R and T applicator is highly dependent upon the size of tumor volume, which, in turn, deviates the applicator during the early course of HDR brachytherapy. Attention to the construction of the midline block is of paramount importance

Additional details

Identifiers

PII
S0360301698000261;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
41
Journal Issue
1
Journal Page Range
p. 13-19
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
35011447
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
NEOPLASMS; POSITIONING; RADIATION SOURCE IMPLANTS; SPATIAL DOSE DISTRIBUTIONS; SPECIFICATIONS; UTERUS; VARIATIONS
Descriptors DEC
BODY; DISEASES; FEMALE GENITALS; IMPLANTS; ORGANS; RADIATION DOSE DISTRIBUTIONS; RADIATION SOURCES

Optional Information

Copyright
Copyright (c) 1998 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.